SPY442.64-1.27 -0.29%
DIA348.61+0.74 0.21%
IXIC14,969.97-77.73 -0.52%

BRIEF-Topline Results From Cytosorbents' U.S. Ctc Multicenter Registry Demonstrate High Survival Using Cytosorb® In Critically Ill Covid-19 Patients On Extracorporeal Membrane Oxygenation (Ecmo)

reuters.com · 09/01/2021 07:29
BRIEF-Topline Results From Cytosorbents' U.S. Ctc Multicenter Registry Demonstrate High Survival Using Cytosorb® In Critically Ill Covid-19 Patients On Extracorporeal Membrane Oxygenation (Ecmo)

- Cytosorbents Corp CTSO:

  • TOPLINE RESULTS FROM CYTOSORBENTS' U.S. CTC MULTICENTER REGISTRY DEMONSTRATE HIGH SURVIVAL USING CYTOSORB® IN CRITICALLY ILL COVID-19 PATIENTS ON EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)

Source text for Eikon: ID:nPnbM4hsSa

Further company coverage: CTSO


((Reuters.Briefs@thomsonreuters.com;))